Cipla targets 50 global filings, focusing on innovation, biosimilars, and complex generics to expand US and Europe presence and strengthen chronic therapy leadership.
India clears Wockhardt’s Zaynich, a novel antibiotic for drug-resistant infections, backed by strong Phase 3 data, offering an effective treatment option for complicated UTIs and severe Gram-negative cases.
P&G Health stock surges 18% after strong Q4 results with 56% profit growth and margin expansion, driven by brand strength, supply chain efficiency, and steady demand outlook.
Tieten Medicity Hospital has successfully performed one of Thane’s first robotic telesurgeries for gall bladder removal (robotic cholecystectomy) using the indigenously developed Mizzo Endo 4000 robotic surgical system.
Sun Pharma reported a strong financial performance for the fourth quarter of FY26, with Sun Pharma Q4 revenue rising 13.6 per cent to Rs. 14,560 crore and Sun Pharma net profit jumping 26.2 per cent to Rs. 2,714 crore, reflecting healthy growt...
.jpeg)
Indian drugmakers deepen US market focus despite export decline in FY26, driven by pricing pressure, generics slowdown, and shift toward specialty drugs and local manufacturing.
Venus Remedies has strengthened its footprint in the Gulf region after receiving Marketing Authorization from the Saudi Food and Drug Authority for Plerixafor, a specialty injectable used in stem cell transplantation procedures.
The pharmaceutical outsourcing landscape is undergoing its most consequential structural transformation in decades—and Indian CDMO players are leading the charge. As global drug innovators race to compress timelines and de-risk capital-intensive...
India-US cooperation is rapidly becoming a key driver of innovation in biotech and healthcare, with both nations expanding partnerships in biotechnology, nuclear medicine, advanced research, and healthcare technology.
Strides Pharma Science Ltd today announced its consolidated financial results for the quarter (Q4FY26) and Full Year (FY26) ended March 31, 2026. Badree Komandur, MD & Group CEO, commented on the performance and said, “Strides continued to deliver...
.jpg)
, CDSCO.jpg)